Interestingly, this combination effect could be extended to other HDAC inhibitor with QC, as panobinostat, a novel approved broad-spectrum HDAC inhibitor30, also has synergistic effects with QC in inducing cell death of T-ALL cells (Supplementary Fig. S2, Table 3, and Table 4). The gene discussed is HDAC9; the disease is acute lymphoblastic leukemia.